DeepMind Health set up an Independent Review Panel in 2016 to provide an oversight of the company’s work with the NHS. The Panel meets four times a year to scrutinise DeepMind Health’s activities including their data sharing agreements, privacy and security measures, and products, and will publish their second report on 15 June.
This year’s report has a broader scope than the first report, and has not only revisited areas of concern identified in 2017 and the progress made, but also addressed three new topics: DeepMind Health’s business model and relationship with Alphabet, additional work on human factors, and evidence of clinical utility. The report also outlines a set of 12 principles to provide a framework for ethical behaviour for DeepMind Health and other companies working in the health sector.
Dr Julian Huppert, Chair of the Independent Panel of Reviewers, former MP for Cambridge, and Director of the Intellectual Forum at Jesus College, Cambridge.
Prof Donal O’Donoghue, Professor of Renal Medicine, University of Manchester
Elisabeth Buggins, Chair, Eastern Academic Health Science Network